BIOMAT Database Logo BIOMAT Database Logo

The immunologic role of IFN-gamma in ACI to Lewis kidney transplantation. 1998

J D Naar, and R A Fisher, and B H Saggi, and V Obias, and W C Goggins, and J W Tawes, and P E Wakely, and M P Posner
Division of Transplant Surgery, Medical College of Virginia/Virginia Commonwealth University, Richmond, Virginia, 23298-0254, USA.

BACKGROUND One of the proposed mechanisms of tolerance induction is the Th-1/Th-2 paradigm. The Th-1 cell is proinflammatory, secreting IFN-gamma and IL-2. Conversely, the Th-2 cell is anti-inflammatory, secreting IL-4 and IL-10. In our earlier studies a shift toward Th-2 dominance was required for tolerance induction in this model. METHODS ACI and Lewis rats were used as donors and recipients, respectively. Twelve hours prior to engraftment, rapamycin 1.5 mg/kg po and cyclosporin 10 mg/kg sc were given, followed by 5 mg/kg sc postop (days 1-7). Lewis rats were used as isografts. Functional allograft tolerance was induced consistently in 100% of the recipients with 50% of the allografts exhibiting normal histology beyond 120 days. Qualitative RT-PCR was performed on the grafts to determine IFN-gamma expression with beta-actin housekeeping gene as control. RESULTS IFN-gamma was expressed in all untreated allografts (5/5) and all treated, yet rejecting, allografts (4/4). None of the isografts (0/5) or histologically tolerant allografts (0/4) expressed IFN-gamma. This distribution was statistically significant (P < 0.001, Fischer's exact test). CONCLUSIONS Our findings support a shift from Th-2 to Th-1 predominance as the corollary mechanism responsible for preventing histologic tolerance.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008297 Male Males
D011090 Polyenes Hydrocarbons with more than one double bond. They are a reduced form of POLYYNES. Cumulenes
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions

Related Publications

J D Naar, and R A Fisher, and B H Saggi, and V Obias, and W C Goggins, and J W Tawes, and P E Wakely, and M P Posner
[Spleen transplantation in the dog. Immunologic role of the spleen in combined spleen-kidney transplantation].
July 1982, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B,
J D Naar, and R A Fisher, and B H Saggi, and V Obias, and W C Goggins, and J W Tawes, and P E Wakely, and M P Posner
Immunologic monitoring in kidney transplantation.
August 1991, Transplantation proceedings,
J D Naar, and R A Fisher, and B H Saggi, and V Obias, and W C Goggins, and J W Tawes, and P E Wakely, and M P Posner
[Immunologic considerations in kidney transplantation].
January 1971, L'union medicale du Canada,
J D Naar, and R A Fisher, and B H Saggi, and V Obias, and W C Goggins, and J W Tawes, and P E Wakely, and M P Posner
[Kidney transplantation. Immunologic problems].
June 1971, Munchener medizinische Wochenschrift (1950),
J D Naar, and R A Fisher, and B H Saggi, and V Obias, and W C Goggins, and J W Tawes, and P E Wakely, and M P Posner
The Lewis system and kidney transplantation.
May 1980, Transplantation,
J D Naar, and R A Fisher, and B H Saggi, and V Obias, and W C Goggins, and J W Tawes, and P E Wakely, and M P Posner
The role of IFN-gamma in tumor transplantation immunity and inhibition of chemical carcinogenesis.
April 2003, Current opinion in immunology,
J D Naar, and R A Fisher, and B H Saggi, and V Obias, and W C Goggins, and J W Tawes, and P E Wakely, and M P Posner
[Immunologic prerequisites of kidney transplantation].
April 1967, Wiener klinische Wochenschrift,
J D Naar, and R A Fisher, and B H Saggi, and V Obias, and W C Goggins, and J W Tawes, and P E Wakely, and M P Posner
[Immunologic aspects of kidney transplantation].
January 1987, Medicinski pregled,
J D Naar, and R A Fisher, and B H Saggi, and V Obias, and W C Goggins, and J W Tawes, and P E Wakely, and M P Posner
[Immunologic aspects of kidney transplantation].
February 1986, Therapeutische Umschau. Revue therapeutique,
J D Naar, and R A Fisher, and B H Saggi, and V Obias, and W C Goggins, and J W Tawes, and P E Wakely, and M P Posner
[Clinico-immunologic problems in kidney transplantation].
January 1981, Wiener medizinische Wochenschrift (1946),
Copied contents to your clipboard!